Japanese health authorities are concerned that variants of the coronavirus are driving a nascent fourth wave in the pandemic with just 109 days remaining until the Tokyo Olympics.

Confidence in Covid-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on March 5.

Fujifilm Holdings Corp. will restart a clinical trial in Japan of the company’s antiviral drug Avigan for the treatment of Covid-19, the Nikkei newspaper reported on Feb. 21.

Europe’s oldest person – French nun Sister Andre – survived Covid-19 and will celebrate her 117th birthday, her caregivers said.

AstraZeneca Plc will file for Japanese approval of the company’s Covid-19 vaccine as early as mid-February, the Yomiuri newspaper reported, marking the second vaccine maker to seek approval in Japan.

Reuters found new evidence that the U.S. Centers for Disease Control and Prevention’s (CDC) response to the pandemic was marred by actions – or inaction – by the agency’s career scientists and frontline staff.

Japan’s Covid-19 cases reached a new daily record on Jan. 6, as the government faced mounting pressure from health experts to impose a strict state of emergency for the Tokyo greater metropolitan area.

A Covid-19 vaccine being developed by CSL Ltd. and the University of Queensland was scrapped after numerous vaccine recipients reported receiving false positives on certain HIV tests, according to the Wall Street Journal.

Shionogi & Co. is planning clinical trials by year-end 2020 for what may be one of Japan’s first domestically produced Covid-19 vaccines to reach the market, as the globe races to secure enough doses to battle the pandemic.

Pfizer Inc. and BioNTech SE announced the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the novel coronavirus.